Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
45.50
27.97
46.44
58.93
20.80
12.38
Shareholder's Funds
45.50
27.97
46.44
58.93
20.80
12.38
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
7.99
5.48
3.94
4.33
2.65
2.52
Secured Loans
7.99
5.48
3.94
4.33
2.65
2.52
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
-0.60
-1.35
-0.87
-0.19
-0.17
Other Long Term Liabilities
0
0
0
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
2.14
0.00
0.00
0.00
0.00
0.00
Current Liabilities
Trade Payables
4.91
4.59
3.08
5.31
2.69
1.94
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
20.31
13.75
13.10
11.21
8.00
5.45
Total Liabilities
67.95
41.72
59.54
70.14
28.80
17.84
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
22.01
21.04
21.54
23.65
9.52
9.03
Less: Accumulated Depreciation
6.66
6.05
5.71
5.78
5.09
4.46
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
15.34
14.99
15.83
17.87
4.43
4.57
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.71
0.69
0.70
0.74
0.73
0.70
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
16.32
16.45
18.03
19.66
5.97
5.61
Current Assets Loans & Advances
Current Investments
0.00
0.00
13.15
13.73
0.00
0.00
Inventories
2.72
3.52
2.22
5.20
1.91
2.62
Sundry Debtors
12.91
11.01
15.18
15.57
10.87
6.42
Cash and Bank
29.50
5.29
5.71
8.08
10.06
3.18
Other Current Assets
50.79
21.81
36.27
42.81
22.84
12.21
Short Term Loans and Advances
5.67
1.98
0.00
0.24
0.00
0.00
Total Current Assets
51.64
25.27
41.51
50.48
22.84
12.23
Net Current Assets (Including Current Investments)
31.32
11.52
28.41
39.27
14.83
6.78
Total Current Assets Excluding Current Investments
51.64
25.27
41.51
50.48
22.84
12.23
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
67.95
41.72
59.54
70.14
28.80
17.84
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
7.99
5.48
3.94
4.33
2.65
2.52
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Sep 2024 is 2.33% vs -5.31% in Sep 2023
Investments
YoY Growth in year ended Sep 2024 is 2.90% vs -1.43% in Sep 2023
Current Assets
YoY Growth in year ended Sep 2024 is 104.35% vs -39.12% in Sep 2023
Compare Balance Sheet Results of Universe Pharmaceuticals, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
45.50
8.52
36.98
434.04%
Shareholder's Funds
45.50
8.52
36.98
434.04%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
7.99
0.00
7.99
0.00%
Secured Loans
7.99
0
7.99
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0.85
-0.85
-100.00%
Other Long Term Liabilities
0
0.85
-0.85
-100.00%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
2.14
0.85
1.29
151.76%
Current Liabilities
Trade Payables
4.91
9.34
-4.43
-47.43%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
20.31
11.23
9.08
80.85%
Total Liabilities
67.95
20.60
47.35
229.85%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
22.01
0
22.01
0.00%
Less: Accumulated Depreciation
6.66
0
6.66
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
15.34
0.00
15.34
0.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.71
0
0.71
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0.18
-0.18
-100.00%
Total Non-Current Assets
16.32
18.88
-2.56
-13.56%
Current Assets Loans & Advances
Current Investments
0
0
0.00
0.00%
Inventories
2.72
0
2.72
0.00%
Sundry Debtors
12.91
0
12.91
0.00%
Cash and Bank
29.50
1.53
27.97
1,828.10%
Other Current Assets
50.79
1.53
49.26
3,219.61%
Short Term Loans and Advances
5.67
0
5.67
0.00%
Total Current Assets
51.64
1.72
49.92
2,902.33%
Net Current Assets (Including Current Investments)
31.32
-9.52
40.84
428.99%
Total Current Assets Excluding Current Investments
51.64
1.72
49.92
2,902.33%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
67.95
20.60
47.35
229.85%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
7.99
0
7.99
0.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 2.14 Million
in Sep 2024Figures in Million
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 15.34 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 2.33% vs -5.31% in Sep 2023
Annual - Investments
Investments 0.71 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 2.90% vs -1.43% in Sep 2023
Annual - Current Assets
Current Assets 51.64 Million
in Sep 2024Figures in Million
YoY Growth in year ended Sep 2024 is 104.35% vs -39.12% in Sep 2023






